Skip to main content
AMGEN INC logo

AMGEN INC — Investor Relations & Filings

Ticker · AMGN ISIN · US0311621009 LEI · 62QBXGPJ34PQ72Z12S66 US Manufacturing
Filings indexed 1,984 across all filing types
Latest filing 2024-08-07 Interim / Quarterly Rep…
Country US United States of America
Listing US AMGN

About AMGEN INC

https://www.amgen.com/

Amgen Inc. is a multinational biotechnology company focused on discovering, developing, manufacturing, and delivering innovative human therapeutics. As a pioneer in the field, the company utilizes advanced science and technology, including genetics and molecular engineering, to create biologic medicines from living cells. Amgen's portfolio and pipeline target serious illnesses with limited treatment options across key therapeutic areas, including oncology, cardiovascular disease, inflammation, bone health, and neuroscience. The company's mission is to translate scientific promise into therapies that restore health and improve the lives of patients worldwide.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q2 2024
2024-08-07 English
8-K
Regulatory Filings
2024-08-06 English
PRIMARY DOCUMENT
Director's Dealing
2024-08-01 English
2023 PUERTO RICO PLAN 11-K
Regulatory Filings
2024-06-21 English
2023 U.S. PLAN 11-K
Regulatory Filings
2024-06-21 English
S-8
Regulatory Filings
2024-06-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.